|
![]() |
|||
|
||||
OverviewThe first edition of this manual appeared in 1992 and was entitled ECAT Assay Procedures. This completely revised new edition combines the strengths of the first edition with new and useful features. It still gives detailed descriptions of the recommended assays and their alternatives. However, the manual now has a broader scope because it is no longer limited by the frontiers of ECAT. Experts all over the world have contributed to this edition. Furthermore, new assays have been introduced, improvements have be en suggested for other assays, while a few others have become redundant or no longer available. The list of manufacturers is fully updated and a list of the recommended nomenclature of quantities in thrombosis and haemostasis is new to this edition, further facilitating the use of this manual. This will contribute to furthering the much needed harmonization and standardization of tests within the field and would be useful in all working haemostasis laboratories. Full Product DetailsAuthor: J. Jespersen , R.M. Bertina , F. HaverkatePublisher: Springer Imprint: Springer Edition: 2nd rev. ed. 1999 Dimensions: Width: 15.50cm , Height: 1.90cm , Length: 23.50cm Weight: 1.410kg ISBN: 9780792353171ISBN 10: 079235317 Pages: 308 Publication Date: 31 December 1998 Audience: Professional and scholarly , Professional & Vocational Format: Hardback Publisher's Status: Active Availability: In Print ![]() This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us. Table of Contents"1 Introduction to laboratory assays in haemostasis and thrombosis.- 2 Good medical laboratory services — guidelines.- 3 Blood collection and sample preparation: pre-analytical variation.- 4 Quality assessment of haemostatic assays and external quality assessment schemes.- 5 Activated partial thromboplastin time (APTT).- 6 Prothrombin time (PT).- 7 Endogenous thrombin potential.- 8 Fibrinogen.- 9 Activated factor VII.- 10 Factor VII activity and antigen.- 11 Factor VIII clotting activity.- 12 Von Willebrand factor.- 13 Antithrombin activity and antigen.- 14 Protein C activity and antigen.- 15 Protein S antigen.- 16 Protein S activity.- 17 Activated protein C (APC) resistance.- 18 Tissue factor pathway inhibitor (TFPI).- 19 Lupus anticoagulant.- 20 Heparin cofactor II.- 21 Fibrinopeptide A (FPA).- 22 Thrombin-antithrombin (TAT) complexes.- 23 Prothrombin fragment F1+2.- 24 Tissue-type plasminogen activator (t-PA) activity.- 25 Tissue-type plasminogen activator antigen (t-PA Ag).- 26 Plasminogen activator inhibitor-1 (PAI-1) antigen.- ""10.1007/978-94-011-4722-4_27"".- 28 Plasmin inhibitor activity (previously ?2-antiplasmin).- 29 Plasmin-?2-antiplasmin complexes (plasmin-plasmin inhibitor complexes).- 30 Soluble fibrin and degradation products of fibrinogen (FgDP), fibrin (FbDP; D-dimer) and total of FgDP and FbDP (TDP).- 31 Venous occlusion test in fibrinolysis assays.- 32 List of manufacturers."Reviews'The objective towards standardization is largely met, since world experts on each assay collaborated to evaluate and compare the available methodologies and point to the advantages and disadvantages of each one. This book is written for clinical thrombosis and hemostasis laboratorians. Another attractive feature is the degree of expertise recruited to produce these critical summaries of existing methodologies. This book is a long overdue update of the first edition in view of the multitude of newly developed methodologies and the number of manufacturers involved.' Demetra D. Callas, Loyola University Medical Center in Doody Publishing Inc. The objective towards standardization is largely met, since world experts on each assay collaborated to evaluate and compare the available methodologies and point to the advantages and disadvantages of each one. This book is written for clinical thrombosis and hemostasis laboratorians. Another attractive feature is the degree of expertise recruited to produce these critical summaries of existing methodologies. This book is a long overdue update of the first edition in view of the multitude of newly developed methodologies and the number of manufacturers involved.' Demetra D. Callas, Loyola University Medical Center in Doody Publishing Inc. Author InformationTab Content 6Author Website:Countries AvailableAll regions |